23 May 2022 Bionest New CheckPoint Inhibitor Therapeutic Approved, More on the Way What effect will the introduction of Opdualag’s fixed-dose combination have on the future of checkpoint inhibitor development and approvals?
9 May 2022 Bionest Moving Towards a Unified EU Health Policy – Beating Cancer Report Approved The European Parliament's Beating Cancer (BECA) report addresses cancer prevention, diagnosis & treatment, with an emphasis on ensuring equitable access to quality care and support for cancer survivors and their families.